Q5148 Injection, nyposi 1 micrograms
Also known as: CGRP antagonist, nyposi, migraine preventive
Injection of nyposi (calcitonin gene-related peptide antagonist), administered at 1 microgram per dose.
In Plain Language
migraine injection; headache prevention; nerve pain blocker
Clinical Context
Used for preventive treatment of episodic or chronic migraine in adults. Administered subcutaneously monthly as a disease-modifying therapy targeting calcitonin gene-related peptide pathways.
RVU Information
CPT Q5148 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5148?
CPT Q5148 (Injection, nyposi 1 micrograms) is a Q Codes code. Injection of nyposi (calcitonin gene-related peptide antagonist), administered at 1 microgram per dose.
Is Q5148 covered by insurance?
Q5148 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for preventive treatment of episodic or chronic migraine in adults. Administered subcutaneously monthly as a disease-modifying therapy targeting calcitonin gene-related peptide pathways.
When is CPT Q5148 used?
Used for preventive treatment of episodic or chronic migraine in adults. Administered subcutaneously monthly as a disease-modifying therapy targeting calcitonin gene-related peptide pathways.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.